A research proposal to study the life cycle of COV
DOI:
https://doi.org/10.47611/jsrhs.v10i2.1434Keywords:
Chemical Genetics, SARS-COV2, Viral Cycle, High Through-put Screen, Bakers’ YeastAbstract
SARS-CoV2 continues to affect the lives of the majority of the world, and although vaccines are beginning to become available, much of the world will still be unable to obtain them. Furthermore, some studies have suggested that there may have to be annual vaccines and as strains of the virus continue to increase, it is essential for us to move to the next stage of research and attempt to better understand the virus.
By utilizing a chemical genetics approach where numerous ligands of distinct chemical libraries are screened through high-throughput screening, we may be able to form an ordered viral cycle of metabolic events that could help identify drug targets more efficiently and coordinate drug use to improve efficacy. A modified version of the virus (to decrease its ability of infection) along with the URA3 protein is then inserted into yeast cells (Saccharomyces cerevisiae) and screened. A simple assay involving the addition of 5’- fluoroorotic acid helps to determine ligand interference and after identifying the compounds, we can order their action into specific steps in the lifecycle and order the events of the life cycle.
Downloads
References or Bibliography
World Health Organisation. (2020) WHO Coronavirus Disease (COVID-19) Dashboard. World Health Organization. World Health Organization.
Poduri, R., Joshi, G., and Jagadeesh, G. (2020, October) Drugs targeting various stages of the SARS-CoV-2 life cycle: Exploring promising drugs for the treatment of Covid-19.
Young, B., Tan, T. T., and Leo, Y. S. (2020, November 26) The place for remdesivir in COVID-19 treatment. The Lancet Infectious Diseases. Elsevier.
Poduri, R., Joshi, G., and Jagadeesh, G. (2020, October) Drugs targeting various stages of the SARS-CoV-2 life cycle: Exploring promising drugs for the treatment of Covid-19. Cellular signalling. Elsevier Science Ltd.
Ward, H., Atchison, C. J., Whitaker, M., Ainslie, K. E. C., Elliott, J., Okell, L. C., Redd, R., Ashby, D., Donnelly, C. A., Barclay, W., Darzi, A., Cooke, G., Riley, S., and Elliott, P. (2020, January 1) Antibody prevalence for SARS-CoV-2 in England following first peak of the pandemic: REACT2 study in 100,000 adults. medRxiv. Cold Spring Harbor Laboratory Press.
Ledford, H., Cyranoski, D., and Noorden, R. V. (2020, December 3) The UK has approved a COVID vaccine - here's what scientists now want to know. Nature News. Nature Publishing Group.
(2020, November 24) The COVID vaccine challenges that lie ahead. Nature News. Nature Publishing Group.
Mittal, A., Manjunath, K., Ranjan, R. K., Kaushik, S., Kumar, S., and Verma, V. (2020, August 21) COVID-19 pandemic: Insights into structure, function, and hACE2 receptor recognition by SARS-CoV-2. PLOS Pathogens. Public Library of Science.
Astuti, I., and Ysrafil. (2020) Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): An overview of viral structure and host response. Diabetes & metabolic syndrome. Diabetes India. Published by Elsevier Ltd.
Lee, N., Shum, D., König, A., Kim, H., Heo, J., Min, S., Lee, J., Ko, Y., Choi, I., Lee, H., Radu, C., Hoenen, T., Min, J.-Y., and Windisch, M. P. (2018, August 24) High-throughput drug screening using the Ebola virus transcription- and replication-competent virus-like particle system. Antiviral Research. Elsevier.
Kuzmanov, U., and Emili, A. (2013, April 30) Protein-protein interaction networks: probing disease mechanisms using model systems. Genome medicine. BioMed Central.
Bojadzic, D., and Buchwald, P. (2018) Toward Small-Molecule Inhibition of Protein-Protein Interactions: General Aspects and Recent Progress in Targeting Costimulatory and Coinhibitory (Immune Checkpoint) Interactions. Current topics in medicinal chemistry. U.S. National Library of Medicine.
Astuti, I., and Ysrafil. (2020) Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): An overview of viral structure and host response. Diabetes & metabolic syndrome. Diabetes India. Published by Elsevier Ltd.
Jarvik, J., and Botstein, D. (1973, July) A genetic method for determining the order of events in a biological pathway.
Kao RY;Tsui WH;Lee TS;Tanner JA;Watt RM;Huang JD;Hu L;Chen G;Chen Z;Zhang L;He T;Chan KH;Tse H;To AP;Ng LW;Wong BC;Tsoi HW;Yang D;Ho DD;Yuen KY; (2004, September 11) Identification of novel small-molecule inhibitors of severe acute respiratory syndrome-associated coronavirus by chemical genetics. Chemistry & biology. U.S. National Library of Medicine.
Stockwell, B. R. (2000, November) Chemical genetics: ligand-based discovery of gene function. Nature reviews. Genetics. U.S. National Library of Medicine.
Xiao, G., Peng, K., Zhang, L., Wan, W., Zhu, S., Li, S., Shang, W., Zhang, R., Li, H., and Liu, W. (2020, November 12) High-Throughput Screening of an FDA-Approved Drug Library Identifies Inhibitors against Arenaviruses and SARS-CoV-2. ACS Infectious Diseases.
Zhao, R. Y. (2017, September 18) Yeast for virus research. Microbial cell (Graz, Austria). Shared Science Publishers OG.
Denny, P. (2018, October 16) Yeast: bridging the gap between phenotypic and biochemical assays for high-throughput screening. Taylor & Francis Online. Taylor & Francis.
Price, B. D., Rueckert, R. R., and Ahlquist, P. (1996, September 3) Complete replication of an animal virus and maintenance of expression vectors derived from it in Saccharomyces cerevisiae. Proceedings of the National Academy of Sciences of the United States of America. U.S. National Library of Medicine.
Välimaa, A.-L., Kivistö, A., Virta, M., and Karp, M. (2008, October 16) Real-time Monitoring of Non-specific Toxicity Using a Saccharomyces cerevisiae Reporter System. Sensors (Basel, Switzerland). Molecular Diversity Preservation International (MDPI).
Denny, P. W., and Steel, P. G. (2014, August 13) Yeast as a Potential Vehicle for Neglected Tropical Disease Drug Discovery - P.W. Denny, P.G. Steel, 2015.
Huang, Y., Yang, C., Xu, X.-feng, Xu, W., and Liu, S.-wen. (2020, August 3) Structural and functional properties of SARS-CoV-2 spike protein: potential antivirus drug development for COVID-19. Nature News. Nature Publishing Group.
Attene-Ramos, M. S., Austin, C. P., and Xia, M. (2014, April 14) High Throughput Screening. Encyclopedia of Toxicology (Third Edition). Academic Press.
Huang, J., and Schreiber, S. L. (1997, December 9) A yeast genetic system for selecting small molecule inhibitors of protein-protein interactions in nanodroplets. Proceedings of the National Academy of Sciences of the United States of America. The National Academy of Sciences of the USA.
Flick, J. S., and Johnston, M. (1990, September) Two systems of glucose repression of the GAL1 promoter in Saccharomyces cerevisiae. Molecular and cellular biology. U.S. National Library of Medicine.
Romano, M., Ruggiero, A., Squeglia, F., Maga, G., and Berisio, R. (2020, May 20) A Structural View of SARS-CoV-2 RNA Replication Machinery: RNA Synthesis, Proofreading and Final Capping. Cells. MDPI.
Published
How to Cite
Issue
Section
Copyright (c) 2021 Phelps Tin; Sam Kunes
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Copyright holder(s) granted JSR a perpetual, non-exclusive license to distriute & display this article.
